Edition:
United States

Shanxi C&Y Pharmaceutical Group Co Ltd (300254.SZ)

300254.SZ on Shenzhen Stock Exchange

17.01CNY
26 Apr 2017
Change (% chg)

¥-0.24 (-1.39%)
Prev Close
¥17.25
Open
¥17.35
Day's High
¥17.35
Day's Low
¥16.88
Volume
914,130
Avg. Vol
1,415,016
52-wk High
¥22.99
52-wk Low
¥16.79

Latest Key Developments (Source: Significant Developments)

Shanxi C&Y Pharmaceutical Group sees FY 2017 Q1 net profit to decrease by 10 pct to increase by 10 pct
Tuesday, 11 Apr 2017 03:54am EDT 

Shanxi C&Y Pharmaceutical Group Co Ltd <300254.SZ> : Says FY 2017 Q1 net profit to decrease by 10 percent to increase by 10 percent, or to be 6 million yuan to 7.3 million yuan, compared to net profit of FY 2016 Q1 (6.6 million yuan) .Says stability of operating revenue as main reason for the forecast.  Full Article

Shanxi C&Y Pharmaceutical Group says change of accounting policy
Thursday, 6 Apr 2017 01:44am EDT 

Shanxi C&Y Pharmaceutical Group Co Ltd <300254.SZ> :Says it changed the accounting policy due to national policy requirement.  Full Article

Shanxi C&Y Pharmaceutical Group to pay cash 0.5 yuan per 10 shares as FY 2016 div payment
Thursday, 6 Apr 2017 01:42am EDT 

Shanxi C&Y Pharmaceutical Group Co Ltd <300254.SZ> :Says it plans to pay cash 0.5 yuan per 10 shares as FY 2016 div payment.  Full Article

ShanXi C&Y Pharmaceutical Group expects FY 2016 net profit to increase by 10 to 35 pct
Friday, 27 Jan 2017 03:20am EST 

ShanXi C&Y Pharmaceutical Group Co Ltd <300254.SZ>: Says net profit of FY 2016 expected to increase by 10 percent to 35 percent, or to be 25.2 million to 30.9 million yuan .Says the net profit of FY 2015 was 22.9 million yuan.  Full Article

Shanxi C&Y Pharmaceutical Group shareholder unloads 3.65 pct stake in co
Sunday, 20 Nov 2016 10:33pm EST 

Shanxi C&Y Pharmaceutical Group Co Ltd <300254.SZ> :Says its shareholder Zhang Tonghui has reduced its shareholdings in the company by sale of 7.6 million shares (3.65 percent stake) via block trade, and holds 4.33 percent stake down from 7.98 percent after trannsaction.  Full Article

Shanxi C&Y Pharmaceutical Group sees 2016 Q1~Q3 net profit to fluctuate by -10 pct to 10 pct
Sunday, 16 Oct 2016 11:14pm EDT 

Shanxi C&Y Pharmaceutical Group Co Ltd <300254.SZ> :sees 2016 Q1~Q3 net profit to fluctuate by -10 percent to 10 percent, compared to net profit of Q1~Q3 in 2015(30.3 million yuan).  Full Article

Shanxi CY Pharmaceutical Group sees 2016 H1 net profit down 10 pct to up 10 pct
Monday, 18 Jul 2016 09:17am EDT 

Shanxi CY Pharmaceutical Group <300254.SZ>: Says net profit for 2016 H1 down 10 percent to up 10 percent, or to be 17.1 million yuan to 20.9 million yuan .Says the net profit of 2015 H1 was 19 million yuan.  Full Article

Shanxi CY Pharmaceutical Group appoints Zhao Qun as chairman
Thursday, 7 Jul 2016 10:06pm EDT 

Shanxi CY Pharmaceutical Group Co., Ltd. <300254.SZ>:Says it appoints Zhao Qun as chairman, Zuo Xueming as president, Wang Qing as CFO of the co.  Full Article

Shanxi CY Pharmaceutical Group to pay 2015 dividend on July 8
Thursday, 30 Jun 2016 02:20am EDT 

Shanxi CY Pharmaceutical Group Co., Ltd. <300254.SZ>: Says it will pay a cash dividend of 0.5 yuan (before tax) per 10 shares and use additional paid-in capital to distribute two new shares for every 10 shares for 2015, to shareholders of record on June 7 .Says the company's shares will be traded ex-right and ex-dividend on June 8 and the dividend will be paid on June 8.  Full Article

Shanxi C&Y Pharma plans share issue to fund acquisition of Shanxi Powerdone Pharma
Tuesday, 21 Jun 2016 07:00am EDT 

Shanxi C&Y Pharmaceutical Group Co Ltd <300254.SZ> :Says it aims to raise up to 3.1 billion yuan ($471.00 million) in private placement of shares to fund acquisition of Shanxi Powerdone Pharmaceutics.  Full Article

More From Around the Web

No consensus analysis data available.